Table 1.
Baseline characteristics of the patients.
| Parameters | Group 1 n = 40 |
Group 2 n = 31 |
P value |
|---|---|---|---|
| Age (years) | 63.6 ± 9.3 | 62.0 ± 8.6 | 0.465 |
| Male n (%) | 36 (95.0) | 28 (90.3) | 0.445 |
| Symptom n (%) - Intermittent Claudication - Rest pain - Trophic Changes |
35 (87.5) 1 (2.5) 4 (10.0) |
24 (77.4) 4 (12.9) 3 (9.7) |
0.287 |
| Walking distance without claudication (mt) | 99.4 ± 67.8 | 61.7 ± 53.6 | 0.018 |
| HT n (%) | 35 (87.5) | 25 (80.6) | 0.429 |
| HL n (%) | 20 (50.0) | 15 (48.4) | 0.324 |
| Current smoker n (%) | 19 (47.5) | 15 (48.4) | 0.288 |
| DM n (%) | 17 (52.5) | 21 (67.7) | 0.079 |
| AF n (%) | 1 (2.5) | 3 (9.7) | 0.193 |
| Previous PCI n (%) | 18 (45.0) | 10 (32.3) | 0.276 |
| Previous CABG n (%) | 13 (32.5) | 2 (6.5) | 0.008 |
| Previous peripheral intervention n (%) | 9 (22.5) | 2 (6.5) | 0.061 |
| Stenosis (%) | 92.6 ± 7.5 | 95.7 ± 6.7 | 0.094 |
| CAD n (%) - Normal - Nonobstructive - 1 vessel disease - 2 vessel disease - 3 vessel disease |
1 (2.5) 6 (15.0) 12 (30.0) 18 (45.0) 3 (7.5) |
1 (3.2) 5 (16.1) 10 (32.3) 12 (38.7) 3 (9.7) |
0.987 |
| Rutherford category n (%) - 2 - 3 - 4 - 5 |
14 (38.9) 17 (47.2) 4 (11.1) 1 (2.8) |
2 (6.9) 14 (48.3) 6 (20.7) 7 (27.1) |
0.004 |
| Fontaine grade n (%) - I - IIA - IIB - III - IV |
1 (2.8) 6 (16.7) 15 (41.7) 13 (36.1) 1 (2.8) |
0 1 (3.4) 5 (17.2) 15 (51.7) 8 (27.6) |
0.006 |
| Target vessel n (%) - CIA - SFA - Popliteal - Below the knee |
16 (40.0) 17 (42.5) 5 (12.5) 2 (5) |
14 (45.1) 13 (41.9) 2 (6.4) 2 (6.4) |
0.442 |
| Peripheral intervention n (%) - PTA - Stent - PTA+Stent - Drug eluting balloon |
11 (28.2) 7 (17.9) 21 (53.8) 11 (28.2) |
6 (22.2) 2 (7.4) 19 (70.4) 5 (18.5) |
0.326 |
| Type of stent n (%) - Self -expandable - Balloon expandable |
15 (55.6) 12 (44.4) |
11 (52.4) 10 (47.6) |
0.827 |
| Mean balloon diameter mm | 5.2 ± 1.3 | 4.9 ± 1.7 | 0.503 |
| Mean balloon length mm | 62.6 ± 43.5 | 63.8 ± 37.0 | 0.917 |
| Mean stent diameter mm | 7.4 ± 1.1 | 7.2 ± 1.3 | 0.509 |
| Mean stent length mm | 56.1 ± 36.8 | 59.2 ± 33.8 | 0.714 |
| LVEF (%) | 51.3 ± 13.8 | 50.3 ± 14.6 | 0.776 |
| LVEDD (cm) | 5.0 ± 0.8 | 4.8 ± 0.4 | 0.286 |
| LVESD (cm) | 3.3 ± 1.0 | 3.2 ± 0.6 | 0.870 |
| LA (cm) | 4.1 ± 0.4 | 3.7 ± 0.4 | <0.001 |
| sPAP (mmHg) | 22.5 ± 12.8 | 25.3 ± 16.8 | 0.467 |
HT: Hypertension; HL: Hyperlipidemia; DM: Diabetes mellitus; AF: Atrial fibrillation; PCI: Percutaneous coronary intervention, CABG: Coronary artery bypass grafting, CAD: Coronary artery disease, CIA: Common iliac artery, SFA: Superficial femoral artery; PTA: Percutaneous transluminal angioplasty; LVEF: Left ventricular ejection fraction, LVEDD: Left ventricular end diastolic diameter, LVESD: Left ventricular end systolic diameter, LA: Left atrium, sPAP: Systolic pulmonary artery pressure.